<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2961">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04476745</url>
  </required_header>
  <id_info>
    <org_study_id>2020-PHA-16</org_study_id>
    <nct_id>NCT04476745</nct_id>
  </id_info>
  <brief_title>The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People</brief_title>
  <official_title>The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People With Vitamin D Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applied Science Private University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applied Science Private University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of Weekly 50,000 IU vitamin D3 supplements on the serum levels of selected
      cytokines involved in cytokine storm of Covid-19; A randomized clinical trial in the Covid-19
      uninfected people with vitamin D deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No data are available on the effect of Weekly 50,000 IU vitamin D3 supplements on the serum
      levels of selected cytokines involved in cytokine storm of Covid-19 in the Covid-19
      uninfected Jordanian people with vitamin D deficiency. This study was designed to investigate
      whether a high dose of vitamin D3 (50,000 IU) / week for 8 weeks supplementation has a
      potential effect on cytokine storm of Covid-19; such as IL-1 beta, IL-6, and TNF in the
      Covid-19 uninfected Jordanian people with vitamin D deficiency.

      This study aims to assess whether high doses of vitamin D3 may improve immune responses
      against COVID-19 infection in uninfected Jordanian peoples. We hypothesize that Weekly 50,000
      IU vitamin D3 supplements will significantly change immune responses compared with the
      control group.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 5, 2020</start_date>
  <completion_date type="Anticipated">December 5, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IL-1 beta</measure>
    <time_frame>8 weeks</time_frame>
    <description>seum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-6</measure>
    <time_frame>8 weeks</time_frame>
    <description>serum levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TNF</measure>
    <time_frame>8 weeks</time_frame>
    <description>serum levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum concentrations of 25-hydroxyvitamin D</measure>
    <time_frame>8 weeks</time_frame>
    <description>ng/ml</description>
  </secondary_outcome>
  <other_outcome>
    <measure>lipid profile parameters</measure>
    <time_frame>8 weeks</time_frame>
    <description>seum levels</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cytokine Storm</condition>
  <arm_group>
    <arm_group_label>Experimental: VD3 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary Supplement: Dietary Supplement: Vitamin D3 Dietary Supplement: Vitamin D3 (50,000) IU / week for 8 weeks Other Names: cholecalciferol,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group No intervention was given</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Dietary Supplement: Vitamin D3 (50,000) IU / week for 8 weeks</description>
    <arm_group_label>Experimental: VD3 group</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age â‰¥30 years old Male and female Jordanian ASU students and employees who live in Amman.
        Informed written consent from the participant prior to the start of the study. a serum
        25(OH)D concentration less than 30 ng/mL.

        Exclusion Criteria:

        Any eligible subject refuses to apply with informed written consent before the start of the
        study. Men or women previously diagnosed with chronic diseases, including kidney disease or
        GIT problems. Who are receiving vitamin D3 supplements (3 months before the start of the
        study). Pregnant, Breastfeeding females, Females using hormonal contraceptives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>66 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud S Abu-Samak, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dana A Bader, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacy and Therapeutics , Applied Science Private University, Amman -Jordan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud S Abu-Samak, PhD</last_name>
    <phone>009627998920</phone>
    <phone_ext>1104</phone_ext>
    <email>m_abusamak@asu.edu.jo</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mahmoud S Abu-Samak</name>
      <address>
        <city>Amman</city>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 16, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2020</study_first_posted>
  <last_update_submitted>July 18, 2020</last_update_submitted>
  <last_update_submitted_qc>July 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Applied Science Private University</investigator_affiliation>
    <investigator_full_name>Mahmoud Suleiman Abu-Samak</investigator_full_name>
    <investigator_title>Mahmoud S Abu-Samak, PhD Study Principal Investigator Department of Clinical Pharmacy and Therapeutics</investigator_title>
  </responsible_party>
  <keyword>Covid -19</keyword>
  <keyword>uninfected</keyword>
  <keyword>IL-1</keyword>
  <keyword>IL-6</keyword>
  <keyword>TNF</keyword>
  <keyword>VDD</keyword>
  <keyword>Vitamin D3</keyword>
  <keyword>50,000IU</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

